CD9 and prostate cancer: Based on this observation and assumption, we further extracted the exosomes from the cell culture medium of prostate cancer cells, performed western blot analysis and confirmed their identity using positive exosome markers (Annexin, EpCam, CD54, CD9 and flotillin).